4

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

SEC Filing Details

Document Details

Form
Filing Date
Sep 15, 2017
Document Date
Sep 12, 2017
Form Description

Statement of changes in beneficial ownership of securities

Filing Group
3,4,5
Company
KemPharm
Issuer
KEMPHARM INC